Brief: Ocumension Therapeutics Proposes On-Market Share Repurchase In Open Market From Time To Time
29/11/2023 01:17
Nov 29 (Reuters) - Ocumension Therapeutics 1477.HK :
* PROPOSED ON-MARKET SHARE REPURCHASE IN OPEN MARKET FROM
TIME TO
TIME USING UP TO AGGREGATE HK$100 MILLION IN FUNDS
Further company coverage: 1477.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ocumension Therapeutics
See all newsBrief: Ocumension Therapeutics Says NMPA Accepts NDA For OT-301 (NCX 470, Bimatoprost Grenod)
Brief: Ocumension Therapeutics Says Dexamethasone Intraocular Suspension Application Accepted By NMPA
Brief: Ocumension Therapeutics Says HY Adjusted Net Loss Rmb57.5 Million
China's Ocumension Therapeutics H1 revenue surges on higher ophthalmic product sales
Ocumension jumps most in three months on China nod for new drug application